BOCM
PFE icon

Bontempo Ohly Capital Management’s Pfizer PFE Stock Holding History

Bontempo Ohly Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-84,793
Closed -$3.12M – 37
2020
Q4 		$3.12M Sell
84,793
-3,376
-4% -$124K 1.87% 17
2020
Q3 		$3.07M Buy
88,169
+82
+0.1% +$2.88K 2.09% 12
2020
Q2 		$2.73M Sell
88,087
-97
-0.1% -$3.29K 1.93% 13
2020
Q1 		$2.73M Buy
88,184
+12,530
+17% +$427K 2.27% 8
2019
Q4 		$2.81M Buy
75,654
+1,281
+2% +$45.6K 1.87% 20
2019
Q3 		$2.54M Buy
74,373
+1,597
+2% +$58.1K 1.8% 21
2019
Q2 		$2.99M Buy
72,776
+599
+0.8% +$23.8K 2.17% 13
2019
Q1 		$2.91M Sell
72,177
-30,730
-30% -$1.23M 2.11% 12
2018
Q4 		$4.26M Buy
102,907
+1,958
+2% +$81.3K 3.16% 3
2018
Q3 		$4.22M Buy
100,949
+5,475
+6% +$211K 2.81% 4
2018
Q2 		$3.29M Buy
95,474
+1,187
+1% +$40.6K 2.58% 4
2018
Q1 		$3.17M Buy
94,287
+13
+0% +$447 2.53% 4
2017
Q4 		$3.13M Sell
94,274
-9,339
-9% -$318K 2.44% 4
2017
Q3 		$3.51M Buy
103,613
+411
+0.4% +$13.2K 2.72% 4
2017
Q2 		$3.29M Sell
103,202
-1,078
-1% -$34K 2.65% 5
2017
Q1 		$3.38M Sell
104,280
-1,485
-1% -$46.8K 2.71% 6
2016
Q4 		$3.26M Buy
105,765
+569
+0.5% +$17.4K 2.66% 8
2016
Q3 		$3.38M Buy
105,196
+1,828
+2% +$61.1K 2.83% 8
2016
Q2 		$3.45M Buy
103,368
+823
+0.8% +$26.3K 2.98% 6
2016
Q1 		$2.88M Buy
102,545
+5,275
+5% +$151K 2.53% 8
2015
Q4 		$2.98M Buy
97,270
+115
+0.1% +$3.62K 2.83% 5
2015
Q3 		$2.9M Buy
97,155
+624
+0.6% +$20K 2.92% 4
2015
Q2 		$3.07M Sell
96,531
-1,392
-1% -$45.4K 2.98% 5
2015
Q1 		$3.23M Sell
97,923
-125
-0.1% -$3.97K 3.08% 3
2014
Q4 		$2.9M Buy
+98,048
New +$2.81M 2.81% 5

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Bontempo Ohly Capital Management's PFE Position: Q1 2021 in Review

Bontempo Ohly Capital Management sold out of Pfizer (PFE) in Q1 2021, closing a stake of 84,793 shares — an estimated $3.12M sold.

Bontempo Ohly Capital Management first reported a position in PFE in Q4 2014 and held it in 25 quarters. The position peaked at $4.26M in Q4 2018. 2,676 funds tracked by Wall St. Rank hold PFE as of Q1 2021.

  • Bontempo Ohly Capital Management reported no remaining Pfizer position as of Q1 2021 after selling out during the quarter.
  • Bontempo Ohly Capital Management sold 84,793 Pfizer shares in Q1 2021, an estimated $3.12M.
  • Bontempo Ohly Capital Management first reported a position in Pfizer in Q4 2014 and held it in 25 quarters.
  • Bontempo Ohly Capital Management's Pfizer position peaked at $4.26M in Q4 2018.
  • 2,676 funds tracked by Wall St. Rank held Pfizer as of Q1 2021.

Based on Bontempo Ohly Capital Management's 13F filing for Q1 2021, filed 17 May 2021.